Articles

The TGA and NPS Medicinewise have worked together to create two interactive online learning modules

The Australian and New Zealand Governments have agreed to cease efforts to establish a joint therapeutic products regulator, the Australia New Zealand Therapeutic Products Agency (ANZTPA).

The annual report contains information about hip, knee and shoulder orthopaedic implants that are having higher-than-expected rates of revision.

News about information to assist importers, manufacturers and suppliers to determine whether their products are food or therapeutic goods

The TGA begins piloting electronic submissions for registered medicines using the eCTD format, supported by updated software and a revised Module 1 aligned with European standards.

Pharmacy software vendor links to TGA adverse event reporting web service

Consultation on low value turnover exemption (LVT) scheme

The amendments made to the Therapeutic Goods Act 1989 (the Act) by the Therapeutic Goods Amendment (2013 Measures No. 1) Act 2014 commenced on 28 February 2014.

The TGA reviewed studies on tartrazine, a yellow colouring used in medicines, and found it safe when properly labelled, with no strong evidence of harm like allergies or behavioural issues.

Pilot web service for transmission of adverse event reports from medical software to the Therapeutic Goods Administration

THERAPEUTIC GOODS ACT 1989

Undertaking to the Secretary of the Australian Department of Health and Ageing given for the purposes of section 42YL of the Act

The Australian government will introduce a comprehensive package of reforms for Australia's Therapeutic Goods Administration (TGA) to ensure the regulation of medicines and medical devices is more effective and transparent.

The TGA intends to cancel all pain-killers containing dextropropoxyphene - Capadex, Di-Gesic, Doloxene and Paradex - from the Australian Register of Therapeutic Goods (ARTG), from 1 March 2012.

The Australian Customs and Border Protection Service and the Therapeutic Goods Administration have taken part in an international ‘Week of Action’ targeting the online sale of counterfeit and illegal medicines.